1887

Abstract

Summary

The effects of exotoxin A (EXA) from on polymorphonuclear leucocytes (PMNLs) were studied in a mouse model and PA103, which produced EXA, was 20 times more virulent for normal mice than was its EXA-deficient mutant, PA103-29. EXA was detected in the plasma of mice infected with PA103, and its presence correlated with increasing numbers of bacteria in the blood and internal organs. A monoclonal antibody (MAb) against EXA prevented the death of the mice if it was given simultaneously with, or 2 h before, infection with strain PA 103. The number of PMNLs in murine blood decreased by 50% within 30 min of intravenous injection of EXA, but this decrease was prevented by simultaneous or prior injection of MAb to the toxin. EXA inhibited in-vitro phagocytosis and killing of by human and murine PMNLs and decreased the number of the PMNLs by between 60 and 68%. Collectively, these results not only confirm that EXA. is toxic , but also suggest that this toxin accelerates the growth of virulent in mice.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-43-3-169
1995-09-01
2022-11-30
Loading full text...

Full text loading...

/deliver/fulltext/jmm/43/3/medmicro-43-3-169.html?itemId=/content/journal/jmm/10.1099/00222615-43-3-169&mimeType=html&fmt=ahah

References

  1. Cross A. S., Sadoff J. C., Iglewski B. H., Sokol P. A. Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans. J Infect Dis 1980; 142:538–546
    [Google Scholar]
  2. Dick J. D., Shull V., Karp J. E., Valentine J. Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients. Eur J Cancer Clin Oncol 1988; 25:S47–54
    [Google Scholar]
  3. Young L. S., Stevens P., Kaijser B. Gram-negative pathogens in septicaemic infections. Scand J Infect Dis 1988 Suppl 3178–94
    [Google Scholar]
  4. Allured V. S., Collier R. J., Caroll S. F., McKay D. B. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. Proc Natl Acad Sci USA 1986; 83:1320–1324
    [Google Scholar]
  5. Pollack M., Young L. S. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest 1979; 63:276–286
    [Google Scholar]
  6. Liu P. V. Extracellular toxins of Pseudomonas aeruginosa. J Infect Dis 1974; 130:S94–99
    [Google Scholar]
  7. Pollack M. The role of exotoxin A in Pseudomonas disease and immunity. Rev Infect Dis 1983; 5: Suppl 5S979–S984
    [Google Scholar]
  8. Woods D. E., Igrewski B. H. Toxins of Pseudomonas aeruginosa: new perspectives. Rev Infect Dis 1983; 5: Suppl 4S715–S722
    [Google Scholar]
  9. Gray G. L., Smith D. H., Baldridge J. S. Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1984; 81:2645–2649
    [Google Scholar]
  10. Hwang J., FitzGerald D. J., Adhya S., Pastan I. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 1987; 48:129–136
    [Google Scholar]
  11. Lory S., Collier R. J. Expression of enzymic activity by exotoxin A from Pseudomonas aeruginosa. Infect Immun 1980; 28:494–501
    [Google Scholar]
  12. Ohtsuki H., Horigome K., Higuchi A. A Binding of mono-clonal antibody specific for domain Ia/II of Pseudomonas aeruginosa exotoxin A at pH4 strongly neutralizes A-induced cytotoxicity in cell culture and in vivo. Infect Immun 1992; 60:1061–1068
    [Google Scholar]
  13. Singer S. H., Ford M., Kirschstein R. L. Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis. Infect Immun 1972; 5:953–956
    [Google Scholar]
  14. Miyazaki S., Matsunaga T., Kawasaki K. Separate isolation of Clostridium difficile spores and vegetative cells from the feces of newborn infants. Microbiol Immunol 1992; 36:131–138
    [Google Scholar]
  15. Kohzuki T., Eguchi Y., Kato M. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa. J Infect Dis 1993; 167:119–125
    [Google Scholar]
  16. Obayashi T. Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: comparison with conventional procedures and clinical applications. J Lab Clin Med 1984; 104:321–330
    [Google Scholar]
  17. Miyazaki S., Ohno A., Kobayashi I., Uji T., Yamaguchi K., Goto S. Cytotoxic effect of hemolytic culture supernatant from Enterococus faecalis on mouse polymorphonuclear neutrophils and macrophages. Microbiol Immunol 1993; 37:265–270
    [Google Scholar]
  18. Ferrante A., Thong Y. H. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J Immunol Methods 1980; 36:109–117
    [Google Scholar]
  19. Bliss C. I. The method of probits. Science 1934; 79:38–39
    [Google Scholar]
  20. Ohman D. E., Sadoff J. C., Iglewski B. H. Toxin A-deficient mutants of Pseudomonas aeruginosa PA 103: isolation and characterization. Infect Immun 1980; 28:899–908
    [Google Scholar]
  21. Hirakata Y., Furuya N., Tateda K., Kaku M., Yamaguchi K. In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice. Infect Immun 1993; 61:2468–2473
    [Google Scholar]
  22. Scharmann W. Formation and isolation of leucocidin from Pseudomonas aeruginosa. J Gen Microbiol 1976; 93:283–291
    [Google Scholar]
  23. Hayashi T., Kamio Y., Terawaki Y. Purification and characterization of cytotoxin from the crude extract of Pseudomonas aeruginosa. Microb Pathog 1989; 6:103–112
    [Google Scholar]
  24. Hirayama T., Kato I., Matsuda F., Noda M. Crystallization and some properties of leukocidin from Pseudomonas aeruginosa. Microbiol Immunol 1983; 27:575–588
    [Google Scholar]
  25. Zehavi-Willner T. Induction of murine cytolytic T lymphocytes by Pseudomonas aeruginosa exotoxin A. Infect Immun 1988; 56:213–218
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-43-3-169
Loading
/content/journal/jmm/10.1099/00222615-43-3-169
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error